583 related articles for article (PubMed ID: 24077979)
1. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
Tal R; Segars JH
Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979
[TBL] [Abstract][Full Text] [Related]
2. Vascular density, angiogenesis and pro-angiogenic factors in uterine fibroids.
Sajewicz M; Konarska M; Wrona AN; Aleksandrovych V; Bereza T; Komnata K; Solewski B; Maleszka A; Depukat P; Warchoł Ł
Folia Med Cracov; 2016; 56(1):27-32. PubMed ID: 27513836
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and pro-angiogenic factors in uterine fibroids - facts and myths.
Konarska M; Wrona AN; Aleksandrovych V; Bereza T; Sajewicz M; Gach-Kuniewicz B; Lis M; Komnata K; Paziewski M; Maleszka A; Depukat P; Solewski B; Warchoł Ł
Folia Med Cracov; 2016; 56(2):37-43. PubMed ID: 28013320
[TBL] [Abstract][Full Text] [Related]
4. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications.
Ciarmela P; Islam MS; Reis FM; Gray PC; Bloise E; Petraglia F; Vale W; Castellucci M
Hum Reprod Update; 2011; 17(6):772-90. PubMed ID: 21788281
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Angiogenesis of Abnormal Uterine Bleeding and Infertility in Patients with Uterine Fibroids-A Systematic Review.
Don EE; Middelkoop MA; Hehenkamp WJK; Mijatovic V; Griffioen AW; Huirne JAF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108180
[TBL] [Abstract][Full Text] [Related]
7. Uterine fibroid vascularization: from morphological evidence to clinical implications.
Ciarmela P; Delli Carpini G; Greco S; Zannotti A; Montik N; Giannella L; Giuliani L; Grelloni C; Panfoli F; Paolucci M; Pierucci G; Ragno F; Pellegrino P; Petraglia F; Ciavattini A
Reprod Biomed Online; 2022 Feb; 44(2):281-294. PubMed ID: 34848152
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule.
Di Tommaso S; Massari S; Malvasi A; Bozzetti MP; Tinelli A
Mol Hum Reprod; 2013 Jun; 19(6):380-7. PubMed ID: 23355533
[TBL] [Abstract][Full Text] [Related]
9. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium.
Weston G; Trajstman AC; Gargett CE; Manuelpillai U; Vollenhoven BJ; Rogers PA
Mol Hum Reprod; 2003 Sep; 9(9):541-9. PubMed ID: 12900513
[TBL] [Abstract][Full Text] [Related]
10. Growth factors and pathogenesis.
Islam MS; Greco S; Janjusevic M; Ciavattini A; Giannubilo SR; D'Adderio A; Biagini A; Fiorini R; Castellucci M; Ciarmela P
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():25-36. PubMed ID: 26527305
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
13. Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: endothelial phenotype and association with microvascular density.
Nikitenko LL; Cross T; Campo L; Turley H; Leek R; Manek S; Bicknell R; Rees MC
Clin Cancer Res; 2006 Oct; 12(19):5648-58. PubMed ID: 17020966
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
16. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation.
Fleischer R; Weston GC; Vollenhoven BJ; Rogers PA
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):603-14. PubMed ID: 18339583
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma.
Park JY; Chae B; Kim MR
Int J Med Sci; 2022; 19(12):1779-1786. PubMed ID: 36313223
[No Abstract] [Full Text] [Related]
20. The normal human myometrium has a vascular spatial gradient absent in small fibroids.
Aitken E; Khaund A; Hamid SA; Millan D; Campbell S
Hum Reprod; 2006 Oct; 21(10):2669-78. PubMed ID: 16807279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
